Trials / Sponsors / Ascendis Pharma Bone Diseases A/S
Ascendis Pharma Bone Diseases A/S
Industry · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Gre Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases | Phase 3 | 2026-04-01 |
| Completed | A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases | Phase 3 | 2021-02-16 |
| Approved For Marketing | Expanded Access Program of Palopegteriparatide in Patients With Hypoparathyroidism Hypoparathyroidism | — | — |